129 related articles for article (PubMed ID: 28289139)
1. Longitudinal Predictors of Synthetic Cannabinoid Use in Adolescents.
Ninnemann AL; Jeong Choi H; Stuart GL; Temple JR
Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289139
[TBL] [Abstract][Full Text] [Related]
2. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.
Winstock A; Lynskey M; Borschmann R; Waldron J
J Psychopharmacol; 2015 Jun; 29(6):698-703. PubMed ID: 25759401
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Cannabinoid Use Among High School Seniors.
Palamar JJ; Barratt MJ; Coney L; Martins SS
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28893851
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
[TBL] [Abstract][Full Text] [Related]
6. A survey of synthetic cannabinoid consumption by current cannabis users.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
[TBL] [Abstract][Full Text] [Related]
7. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
8. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis.
Kassai S; Pintér JN; Rácz J; Böröndi B; Tóth-Karikó T; Kerekes K; Gyarmathy VA
Harm Reduct J; 2017 Feb; 14(1):9. PubMed ID: 28187774
[TBL] [Abstract][Full Text] [Related]
9. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults.
Caviness CM; Tzilos G; Anderson BJ; Stein MD
Subst Abus; 2015; 36(3):368-73. PubMed ID: 25222129
[TBL] [Abstract][Full Text] [Related]
11. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.
Clayton HB; Lowry R; Ashley C; Wolkin A; Grant AM
Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289138
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation following synthetic cannabinoid abuse.
Efe TH; Felekoglu MA; Çimen T; Doğan M
Turk Kardiyol Dern Ars; 2017 Jun; 45(4):362-364. PubMed ID: 28595208
[TBL] [Abstract][Full Text] [Related]
14. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
Keyes KM; Rutherford C; Hamilton A; Palamar JJ
Drug Alcohol Depend; 2016 Sep; 166():159-67. PubMed ID: 27491817
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting.
Manseau MW; Rajparia A; Joseph A; Azarchi S; Goff D; Satodiya R; Lewis CF
Subst Use Misuse; 2017 May; 52(6):822-825. PubMed ID: 28156305
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
Macfarlane V; Christie G
Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoid and marijuana exposures reported to poison centers.
Forrester MB; Kleinschmidt K; Schwarz E; Young A
Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
[TBL] [Abstract][Full Text] [Related]
18. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
Gudsoorkar VS; Perez JA
Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
[TBL] [Abstract][Full Text] [Related]
19. Marijuana and adolescents.
Nistler C; Hodgson H; Nobrega FT; Hodgson CJ; Wheatley R; Solberg G
Minn Med; 2006 Sep; 89(9):49-51. PubMed ID: 17024926
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Cannabinoids.
Mills B; Yepes A; Nugent K
Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
